Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

Kraan W, van Keimpema M, Horlings HM, Schilder-Tol EJ, Oud ME, Noorduyn LA, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20. No abstract available.

PMID:
24253023
[PubMed - indexed for MEDLINE]
2.

CD79B and MYD88 mutations in diffuse large B-cell lymphoma.

Kim Y, Ju H, Kim DH, Yoo HY, Kim SJ, Kim WS, Ko YH.

Hum Pathol. 2014 Mar;45(3):556-64. doi: 10.1016/j.humpath.2013.10.023. Epub 2013 Oct 31.

PMID:
24444466
[PubMed - indexed for MEDLINE]
3.

VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type.

Nichele I, Zamò A, Bertolaso A, Bifari F, Tinelli M, Franchini M, Stradoni R, Aprili F, Pizzolo G, Krampera M.

PLoS One. 2012;7(12):e52811. doi: 10.1371/journal.pone.0052811. Epub 2012 Dec 21.

PMID:
23285191
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.

Fujiishi K, Kitazawa R, Nagai Y, Watanabe T, Bando K, Kobayashi S, Yakushijin Y, Haraguchi R, Kitazawa S.

Virchows Arch. 2014 Jan;464(1):121-4. doi: 10.1007/s00428-013-1514-1. Epub 2013 Nov 22. No abstract available.

PMID:
24259032
[PubMed - indexed for MEDLINE]
5.

Oncogenic MYD88 mutation drives Toll pathway to lymphoma.

Jeelall YS, Horikawa K.

Immunol Cell Biol. 2011 Aug;89(6):659-60. doi: 10.1038/icb.2011.31. Epub 2011 Apr 26. No abstract available.

PMID:
21519346
[PubMed - indexed for MEDLINE]
6.

Oncogenically active MYD88 mutations in human lymphoma.

Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM.

Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.

PMID:
21179087
[PubMed - indexed for MEDLINE]
7.

MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.

Choi JW, Kim Y, Lee JH, Kim YS.

Hum Pathol. 2013 Jul;44(7):1375-81. doi: 10.1016/j.humpath.2012.10.026. Epub 2013 Feb 4.

PMID:
23380077
[PubMed - indexed for MEDLINE]
8.

MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type.

Pham-Ledard A, Cappellen D, Martinez F, Vergier B, Beylot-Barry M, Merlio JP.

J Invest Dermatol. 2012 Aug;132(8):2118-20. doi: 10.1038/jid.2012.102. Epub 2012 Apr 12. No abstract available.

PMID:
22495176
[PubMed - indexed for MEDLINE]
Free Article
9.

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM.

Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638.

PMID:
20054396
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma.

Fernández-Rodríguez C, Bellosillo B, García-García M, Sánchez-González B, Gimeno E, Vela MC, Serrano S, Besses C, Salar A.

Leukemia. 2014 Oct;28(10):2104-6. doi: 10.1038/leu.2014.184. Epub 2014 Jun 6. No abstract available.

PMID:
24903481
[PubMed - indexed for MEDLINE]
11.

Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation.

Wang CZ, Lin J, Qian J, Shao R, Xue D, Qian W, Xiao GF, Deng ZQ, Yang J, Li Y, Chen XX.

Clin Biochem. 2013 Mar;46(4-5):385-7. doi: 10.1016/j.clinbiochem.2012.11.007. Epub 2012 Nov 21.

PMID:
23178471
[PubMed - indexed for MEDLINE]
12.

Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.

Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A.

Mod Pathol. 2009 Apr;22(4):547-55. doi: 10.1038/modpathol.2009.10. Epub 2009 Mar 13.

PMID:
19287466
[PubMed - indexed for MEDLINE]
Free Article
13.

[MyD88 L265P mutation and B cell tumor].

Chen HM, Hou J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):241-4. doi: 10.7534/j.issn.1009-2137.2014.01.048. Review. Chinese.

PMID:
24598687
[PubMed - indexed for MEDLINE]
14.

Testicular diffuse large cell lymphoma with tubule preservation--molecular genetic evidence of transformation from previous follicular lymphoma.

Lasota J, Nordling S, Miettinen M.

Virchows Arch. 2000 Mar;436(3):276-83.

PMID:
10782887
[PubMed - indexed for MEDLINE]
15.

EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples.

Saieg MA, Geddie WR, Boerner SL, Bailey D, Crump M, da Cunha Santos G.

Cancer Cytopathol. 2013 Jul;121(7):377-86. doi: 10.1002/cncy.21262. Epub 2013 Jan 29.

PMID:
23361872
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Primary diffuse large B-cell lymphoma of the testis.

Horne MJ, Adeniran AJ.

Arch Pathol Lab Med. 2011 Oct;135(10):1363-7. doi: 10.5858/arpa.2010-0158-RS. Review.

PMID:
21970494
[PubMed - indexed for MEDLINE]
17.

Molecular pathological analysis of testicular diffuse large cell lymphomas.

Hyland J, Lasota J, Jasinski M, Petersen RO, Nordling S, Miettinen M.

Hum Pathol. 1998 Nov;29(11):1231-9.

PMID:
9824100
[PubMed - indexed for MEDLINE]
18.

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.

Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Blood Cancer J. 2013 Sep 6;3:e139. doi: 10.1038/bcj.2013.28.

PMID:
24013661
[PubMed]
Free PMC Article
19.

T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.

Kuper-Hommel MJ, Schreuder MI, Gemmink AH, van Krieken JH.

Mod Pathol. 2013 Mar;26(3):421-7. doi: 10.1038/modpathol.2012.170. Epub 2012 Sep 28.

PMID:
23018871
[PubMed - indexed for MEDLINE]
Free Article
20.

Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.

Yamada S, Ishida Y, Matsuno A, Yamazaki K.

Leuk Lymphoma. 2015 Jan 14:1-5. [Epub ahead of print]

PMID:
25347427
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk